Skip to content

Frontlight ResearchEarly access

Trial site

CTCA Southwestern (Site 0060)

Tulsa, Oklahoma 74133, United StatesNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Gastric and oesophageal cancer

Closed trials

Completed
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
NCT03615326· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

CTCA Southwestern (Site 0060): trial site – Frontlight Research